Zalcitabine and didanosine

This publication has 22 references indexed in Scilit:

• Nucleoside Therapy for HIV Infection — Some Answers, Many Questions
  New England Journal of Medicine, 1992
• Combination Therapy with Zidovudine and Dideoxycytidine in Patients with Advanced Human Immunodeficiency Virus Infection
  Annals of Internal Medicine, 1992
• Clinical Pharmacology of 2',3'-Dideoxyinosine in Human Immunodeficiency Virus-Infected Children
  The Journal of Infectious Diseases, 1992
• Food-induced reduction in bioavailability of didanosine
  Clinical Pharmacology & Therapeutics, 1991
• Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome—related complex
  Clinical Pharmacology & Therapeutics, 1991
• Overview of the Preclinical Development of an Antiretroviral Drug, 2′,3′-Dideoxyinosine
  Clinical Infectious Diseases, 1990
• Pharmacodynamics of 2′,3′-dideoxycytidine: An inhibitor of human immunodeficiency virus
  The American Journal of Medicine, 1990
• Human immunodeficiency viruses and the pathogenesis of AIDS
  Published by American Medical Association (AMA) ,1989
• PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)
  The Lancet, 1988
• Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.
  Proceedings of the National Academy of Sciences, 1987